Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;3(6):181-7.
doi: 10.1177/2042018812471070.

Vitamin D and rheumatoid arthritis

Ifigenia Kostoglou-Athanassiou  1 , Panagiotis Athanassiou, Aikaterini Lyraki, Ioannis Raftakis, Christodoulos Antoniadis
Affiliations

Vitamin D and rheumatoid arthritis

Ifigenia Kostoglou-Athanassiou et al. Ther Adv Endocrinol Metab. 2012 Dec.

Abstract

Objectives: Vitamin D deficiency has been implicated in the pathogenesis of autoimmune diseases, such as diabetes mellitus type 1 and multiple sclerosis. Reduced vitamin D intake has been linked to increased susceptibility to the development of rheumatoid arthritis (RA) and vitamin D deficiency has been found to be associated with disease activity in patients with RA. The objective was to evaluate vitamin D status in patients with RA and to assess the relationship between vitamin D levels and disease activity.

Methods: In a cohort of 44 patients with RA, 25-hydroxyvitamin D(3) [25(OH)D(3)] levels, parathyroid hormone levels, C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were measured. Disease activity was evaluated by calculating the 28-joint Disease Activity Score (DAS28). A control group (n = 44), matched for age and sex, was evaluated as well.

Results: In the cohort of 44 patients with RA 25(OH)D(3) levels were found to be low compared with the control group, 25(OH)D(3) being 15.26 ± 1.07 ng/ml [mean ± standard error of the mean (SEM)] and 25.8 ± 1.6 ng/ml in the patient and control group respectively (Student's t test, p < 0.001). Parathyroid hormone levels were 71.08 ± 7.02 pg/ml (mean ± SEM) (normal values 10.0-65.0 pg/ml), CRP 7.6 ± 1.57 mg/litre (mean ± SEM) (normal values < 3 mg/litre) and ESR was 38.0 ± 4.6 mm/h (mean ± SEM) in the group of patients with RA. Levels of 25(OH)D(3) were found to be negatively correlated to the DAS28, the correlation coefficient being -0.084. Levels of 25(OH)D(3) were also found to be negatively correlated to CRP and ESR, the correlation coefficient being -0.115 and -0.18, respectively.

Conclusion: It appears that vitamin D deficiency is highly prevalent in patients with RA, and that vitamin D deficiency may be linked to disease severity in RA. As vitamin D deficiency has been linked to diffuse musculoskeletal pain, these results have therapeutic implications. Vitamin D supplementation may be needed both for the prevention of osteoporosis as well as for pain relief in patients with RA.

Keywords: disease activity; rheumatoid arthritis; vitamin D.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare no conflicts of interest in preparing this article.

Figures

Figure 1.
Figure 1.
25-Hydroxyvitamin D3 [25(OH)D3] levels [ng/ml, mean ± standard error of the mean (SEM)] in the group of patients with rheumatoid arthritis (RA) and in controls.
Figure 2.
Figure 2.
Scatterplot of 25-hydroxyvitamin D3 [25(OH)D3] in relation to the 28-joint Disease Activity Score (DAS28) index in the group of patients with rheumatoid arthritis (RA).
Figure 3.
Figure 3.
Scatterplot of 25-hydroxyvitamin D3 [25(OH)D3] (ng/ml) in relation to C-reactive protein (CRP) (mg/litre) in the group of patients with rheumatoid arthritis (RA).
Figure 4.
Figure 4.
Scatterplot of 25-hydroxyvitamin D3 [25(OH)D3] in relation to erythrocyte sedimentation rate (ESR) (mm/h) in the group of patients with rheumatoid arthritis (RA).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adorini L. (2005) Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell Immunol 233: 115–124 - PubMed
    1. Aletaha D., Neogi T., Silman A., Funovits J., Felson D., Bingham C., III, et al. (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62: 2569–2581 - PubMed
    1. Baker J., Baker D., Toedter G., Shults J., Von Feldt J., Leonard M. (2012) Associations between vitamin D, disease activity, and clinical response to therapy in rheumatoid arthritis. Clin Exp Rheumatol 30: 658–664 - PubMed
    1. Bartels L., Hvas C., Agnholt J., Dahlerup J., Agger R. (2010) Human dendritic cell antigen presentation and chemotaxis are inhibited by intrinsic 25-hydroxy vitamin D activation. Int Immunopharmacol 10: 922–928 - PubMed
    1. Bartley J. (2010) Vitamin D: emerging roles in infection and immunity. Expert Rev Anti Infect Ther 8: 1359–1369 - PubMed